Are you Dr. Edelman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 9 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
801 W Interstate 20
Ste 132
Arlington, TX 76017Phone+1 682-274-8181Fax+1 817-764-0175
Summary
- Dr. Gerald Edelman, MD is an oncologist in Arlington, Texas. He is currently licensed to practice medicine in Texas, Ohio, and New Mexico. He is affiliated with USMD Hospital at Arlington and Texas Health Harris Methodist Hospital Fort Worth.
Education & Training
- University of ColoradoResidency, Internal Medicine, 1986 - 1988
- University of Colorado School of Medicine Anschutz Medical CampusClass of 1985
Certifications & Licensure
- CO State Medical License 1986 - 2025
- TX State Medical License 1993 - 2025
- OH State Medical License 2018 - 2021
- OK State Medical License 2015 - 2021
- NM State Medical License 2015 - 2019
- WI State Medical License 1990 - 1993
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 37 citationsCurrent Ovarian Cancer Maintenance Strategies and Promising New Developments.Vinaya Gogineni, Susan Morand, Hannah Staats, Rachel Royfman, Monika Devanaboyina
Journal of Cancer. 2021-01-01 - 8 citationsFDA efficiency for approval process of COVID-19 therapeutics.Christine S Cassidy, Danielle Dever, Laura Stanbery, Gerald Edelman, Lance D. Dworkin
Infectious Agents and Cancer. 2020-12-01 - 11 citationsPhase I Trial of a Tablet Formulation of Pilaralisib, a Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid TumorsGerald M. Edelman, Jordi Rodon, Joanne Lager, Christelle Castell, Jason Jiang
The Oncologist. 2018-04-01
Press Mentions
- New USMD Cancer Care and Infusion Centers Open to Improve Cancer Care in Dallas-Fort WorthMay 20th, 2021
- 180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to StockholdersMarch 24th, 2021
- Fusion Transcript Discovery Using RNA Sequencing in Formalin-Fixed Paraffin-Embedded SpecimenMarch 20th, 2021